US Patent Office rejects Amarin’s Trigyceride Drug Patent Application
NEW YORK (AP) — Earlier on Thursday, The Street.com reported that the government declined a patent application for Amarin Corp.
Read moreNEW YORK (AP) — Earlier on Thursday, The Street.com reported that the government declined a patent application for Amarin Corp.
Read moreIn an online study published in the journal Ophthalmology, researchers at the University of Michigan Kellogg Eye Center report that
Read moreScientists at Sydney University claim to have developed a drug that can combat both Heart disease and Type 2 diabetes.
Read more